SonoScape Medical (SZSE:300633) Will Want To Turn Around Its Return Trends
SonoScape Medical (SZSE:300633) Will Want To Turn Around Its Return Trends
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. Although, when we looked at SonoScape Medical (SZSE:300633), it didn't seem to tick all of these boxes.
如果你正在尋找一個多包裹公司,有幾件事情要注意。 其中之一是,我們希望看到兩件事情。 首先是,投入資本要不斷增長。 基本上這意味着一家公司有盈利的項目,可以繼續投資,這是一個複合機器的特徵。然而,當我們看着松下醫療設備(SZSE:300633)時,它似乎沒有滿足所有這些條件。資產回報率:它是什麼?如果您不確定ROCE是什麼,它可以衡量公司能夠從其業務所僱用的資本產生多少稅前利潤。爲了計算V2X的這個指數,使用以下公式:0.054 = 1.24億美元÷(31億美元 - 8.53億美元)ROCE 趨勢可以告訴我們什麼?比起 Enphase Energy,有更好的資本回報率選擇。在過去的五年中,該公司增加了 1,306% 的資本,而該資本的回報率保持穩定在 9.9%。這樣差的回報率現在並不令人信服,而且隨着資本的增加,很明顯企業並沒有將資金投入到高回報的投資中。對於那些不了解的人,ROCE是衡量公司年度稅前利潤(它的回報率)與業務中所使用的資本之間關係的一個指標。 在SonoScape Medical的計算公式是:
Understanding Return On Capital Employed (ROCE)
上面您可以看到蒙托克可再生能源現行ROCE與之前資本回報的比較,但過去只能知道這麼多。如果您感興趣,可以查看我們免費的蒙托克可再生能源分析師報告,了解分析師的預測。
For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. The formula for this calculation on SonoScape Medical is:
0.12 = CN¥391m ÷ (CN¥4.0b - CN¥732m)
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
資產僱用回報率(ROCE)是指企業利潤,即企業稅前利潤除以企業投入的總資本(負債加股權)。如果ROCE高於企業財務成本的承受能力,那麼企業就會創造出更多的價值。
0.12 = CN¥391m ÷ (CN¥4.0b - CN¥732m) (Based on the trailing twelve months to March 2024).
因此,松下醫療設備的ROCE爲12%。 獨自看來,這是一個標準回報,但它比醫療設備行業的6.4%要好得多。在Elevance Health上,我們已經注意到的趨勢是相當令人放心的。數據顯示,過去五年資產回報率大幅提高至15%。投資所用資產的規模也增加了30%。這表明有很多機會進行內部資本投資,並以更高的速度不斷增長,這種組合在多倍增長方面很常見。.
Thus, SonoScape Medical has an ROCE of 12%. On its own, that's a standard return, however it's much better than the 6.4% generated by the Medical Equipment industry.
因此,新唐影像醫療的資本回報率爲12%。 單獨看來,這是一種標準的回報,但比醫療設備行業產生的6.4%要好得多。
![roce](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240527/0-d9093b8f7171c306f5e9fa6031f3a403-0-06916b67bd1bc07ba3bf9eceb22c7e4c.png/big)
In the above chart we have measured SonoScape Medical's prior ROCE against its prior performance, but the future is arguably more important. If you'd like, you can check out the forecasts from the analysts covering SonoScape Medical for free.
因此,SonoScape Medical的ROCE趨勢如何? 當我們查看SonoScape Medical的ROCE趨勢時,我們沒有獲得太多信心。 在過去五年中,資本回報率從五年前的17%降至12%。 然而,鑑於資本投入和營業收入都有所增加,似乎該業務目前正在追求增長,這是短期回報的代價。 如果增加的資本產生了額外的回報,業務和股東將從長遠來看受益。
So How Is SonoScape Medical's ROCE Trending?
雖然SonoScape Medical的回報率近年來有所下降,但我們很高興看到銷售額在增長,並且該業務正在對其運營進行再投資。鑑於此,該股票過去五年僅增長了38%。因此,如果其他基本面證明良好,則該股票仍可能是一個吸引人的投資機會。
When we looked at the ROCE trend at SonoScape Medical, we didn't gain much confidence. Over the last five years, returns on capital have decreased to 12% from 17% five years ago. However, given capital employed and revenue have both increased it appears that the business is currently pursuing growth, at the consequence of short term returns. And if the increased capital generates additional returns, the business, and thus shareholders, will benefit in the long run.
當我們查看新唐影像醫療的資本回報率趨勢時,我們沒有獲得太多信心。 在過去的五年中,資本回報率從五年前的17%下降到12%。 然而,鑑於資本僱用和營業收入均有增加,似乎業務目前正在追求增長,代價是短期回報。 如果增加的資本產生額外的回報,那麼業務和股東將受益於長期。
The Bottom Line
還有一件事需要注意的是,我們已經確定了上海醫藥的2個警告信號,了解這些信號應該成爲你的投資過程的一部分。
While returns have fallen for SonoScape Medical in recent times, we're encouraged to see that sales are growing and that the business is reinvesting in its operations. In light of this, the stock has only gained 38% over the last five years. So this stock may still be an appealing investment opportunity, if other fundamentals prove to be sound.
如果您正在尋找一個多包裹公司,有幾件事情要注意。 其中之一是,投入資本要不斷增長。 基本上這意味着一家公司有盈利的項目,可以繼續投資,這是一個複合機器的特徵。然而,當我們看着松下醫療設備(SZSE:300633)時,它似乎沒有滿足所有這些條件。
Like most companies, SonoScape Medical does come with some risks, and we've found 1 warning sign that you should be aware of.
像大多數公司一樣,新唐影像醫療也存在一些風險,我們發現了1個警告信號,您應該注意。
While SonoScape Medical isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.
雖然松下醫療設備的回報率不是最高的,但請查看此免費的公司列表,這些公司在擁有solide資產負債表的同時具有高回報率。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或電郵 editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。